HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, Iran

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 26, Issue 9, 2014, Pages 1122-1126

  Ramezani, Amitis ^a   Amirmoezi, Reihaneh ^b   Volk, Jonathan E ^c   Aghakhani, Arezoo ^a   Zarinfar, Nader ^d   McFarland, Willi ^e   Banifazl, Mohammad ^f   Mostafavi, Ehsan ^a   Eslamifar, Ali ^a   Sofian, Masoomeh ^d  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^f Iranian Society for Support of Patients with Infectious Diseases   (Iran)

Author keywords

hepatitis B virus; hepatitis C virus; human immunodeficiency virus; injection drug users; Iran; prison; syringe sharing

Indexed keywords

ACETYLSALICYLIC ACID; BUPRENORPHINE; CAFFEINE; CANNABIS; DIAMORPHINE; METHADONE; METHAMPHETAMINE; NORGESIC; OPIATE; ORPHENADRINE;

ADULT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; HEALTH CENTER; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IRAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METHADONE TREATMENT; MIXED INFECTION; PRIORITY JOURNAL; PRISON; SEROLOGY; URBAN AREA;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; INJECTION DRUG USERS; IRAN; PRISON; SYRINGE SHARING;

ADOLESCENT; ADULT; COINFECTION; HEPATITIS B; HEPATITIS C; HIV SEROPREVALENCE; HUMANS; IRAN; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84903269118     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540121.2014.882485     Document Type: Article

References (20)

1. Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A.,., Margolis, H. S. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. The New England Journal of Medicine, 341, 556-562. doi: 10.1056/NEJM199908193410802 (Pubitemid 29384163)
2. Alter, M. J., &, Moyer, L. A. (1998). The importance of preventing hepatitis C virus infection among injection drug users in the United States. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18 (Suppl. 1), S6-S10. doi: 10.1097/00042560-199802001-00003
3. Amin-Esmaeli, M., Rahimi-Movaghar, A., Razaghi, E. M., Baghestani, A. R., &, Jafari, S. (2012). Factors correlated with hepatitis C and B virus infections among injecting drug users in Tehran, IR Iran. Hepatitis Monthly, 12, 23-31.
4. Degenhardt, L., &, Hall, W. (2012). What we know about the extent of illicit drug use, dependence, and their contribution to the global burden of disease. The Lancet, 379, 55-70. doi: 10.1016/S0140-6736(11)61138-0
5. Kassaian, N., Adibi, P., Kafashaian, A., Yaran, M., Nokhodian, Z., Shoaei P.,., Ataei, B. (2012). Hepatitis C virus and associated risk factors among prison inmates with history of drug injection in Isfahan, Iran. International Journal of Preventive Medicine, 3 (Suppl. 1), S156-S161.
6. Kheirandish, P., SeyedAlinaghi, S., Jahani, M., Shirzad, H., Seyed Ahmadian, M., Majidi, A.,., McFarland, W. (2009). Prevalence and correlates of hepatitis C infection among male injection drug users in detention, Tehran, Iran. Journal of Urban Health, 86, 902-908. doi: 10.1007/s11524-009-9393-0
7. Mahanta, J., Borkakoty, B., Das, H. K., &, Chelleng, P. K. (2009). The risk of HIV and HCV infections among injection drug users in northeast India. AIDS Care, 21, 1420-1424. doi: 10.1080/09540120902862584
8. Mathers, B. M., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S. A.,., Mattick, R. P. (2008). Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. The Lancet, 372, 1733-1745. doi: 10.1016/S0140-6736(08)61311-2
9. Ministry of Health (MoH). (2011). Current statistics on HIV/AIDS infection in Islamic Republic of Iran [. in Persian ]. Tehran: Center for Disease Management, MoH.
10. Mir-Nasseri, M. M., Mohammadkhani, A., Tavakkoli, H., Ansari, E., &, Poustchi, H. (2011). Incarceration is a major risk factor for blood-borne infection among intravenous drug users: Incarceration and blood borne infection among intravenous drug users. Hepatitis Monthly, 11 (1), 19-22.
11. Mohtasham Amiri, Z., Rezvani, M., Jafari Shakib, R., &, Jafari Shakib, A. (2007). Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province. Eastern Mediterranean Health, 13, 250-256. (Pubitemid 47045989)
12. Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., &, Degenhardt, L. (2011). Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews. The Lancet, 378, 571-583. doi: 10.1016/S0140-6736(11)61097-0
13. Rockstroh, J. K., &, Spengler, U. (2004). HIV and hepatitis C virus co-infection. Lancet Infection Disease, 4, 437-44. doi: 10.1016/S1473-3099(04) 01059-X (Pubitemid 38844128)
14. Rowhani-Rahbar, A., Rooholamini, S., &, Khoshnood, K. (2004). Prevalence of HIV infection and other blood-borne infections in incarcerated and non-incarcerated injection drug users (IDUs) in Mashhad, Iran. International Journal of Drug Policy, 15, 151-155. doi: 10.1016/j.drugpo.2003.07.001 (Pubitemid 38373954)
15. Samuel, M. C., Doherty, P. M., Bulterys, M., &, Jenison, S. A. (2001). Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street recruited injecting drug users in New Mexico, USA. Epidemiology Infection, 127, 475-484. doi: 10.1017/S0950268801006197 (Pubitemid 34092794)
16. Skoretz, S., Zaniewski, G., &, Goedhuis, N. J. (2004). Hepatitis C virus transmission in the prison/inmate population. Canada Communicable Disease Report, 30, 16-26.
17. Sofian, M., Aghakhani, A., Banifazl, M., Azadmanesh, K., Farazi, A. A., McFarland, W.,., Ramezani, A. (2012). Viral hepatitis and HIV infection among injection drug users in a central Iranian city. Journal of Addiction Medicine, 6, 292-296. doi: 10.1097/ADM.0b013e3182659928
18. SPSS Inc. Released. (2007). SPSS for Windows, version 16.0. Chicago: Author.
19. Stark, K., Bienzle, U., Vonk, R., &, Guggenmoos-Holzmann, I. (1997). History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. International Journal of Epidemiology, 26, 1359-1366. doi: 10.1093/ije/26.6.1359 (Pubitemid 28010456)
20. Xia, X., Luo, J., Bai, J., &, Yu, R. (2008). Epidemiology of hepatitis C virus infection among injection drug users in China: Systematic review and meta-analysis. Public Health, 122, 990-1003. doi: 10.1016/j.puhe.2008.01.014